FGF23 and endothelial dysfunction: Particularly, increased FGF-23 levels in patients with CKD are clinically relevant to CV mortality [22] by inducing left ventricular hypertrophy [23, 24], arterial stiffness combined with endothelial dysfunction [25], and vascular calcification [26].